Literature DB >> 18778722

DNA methylation in development and human disease.

Suhasni Gopalakrishnan1, Beth O Van Emburgh, Keith D Robertson.   

Abstract

DNA methylation is a heritable and stable epigenetic mark associated with transcriptional repression. Changes in the patterns and levels of global and regional DNA methylation regulate development and contribute directly to disease states such as cancer. Recent findings provide intriguing insights into the epigenetic crosstalk between DNA methylation, histone modifications, and small interfering RNAs in the control of cell development and carcinogenesis. In this review, we summarize the recent studies in DNA methylation primarily focusing on the interplay between different epigenetic modifications and their potential role in gene silencing in development and disease. Although the molecular mechanisms involved in the epigenetic crosstalk are not fully understood, unraveling their precise regulation is important not only for understanding the underpinnings of cellular development and cancer, but also for the design of clinically relevant and efficient therapeutics using stem cells and anticancer drugs that target tumor initiating cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18778722      PMCID: PMC2647981          DOI: 10.1016/j.mrfmmm.2008.08.006

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  77 in total

1.  Differential recruitment of methylated CpG binding domains by the orphan receptor GCNF initiates the repression and silencing of Oct4 expression.

Authors:  Peili Gu; Damien Le Menuet; Arthur C-K Chung; Austin J Cooney
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

2.  Synergistic function of DNA methyltransferases Dnmt3a and Dnmt3b in the methylation of Oct4 and Nanog.

Authors:  Jing-Yu Li; Min-Tie Pu; Ryutaro Hirasawa; Bin-Zhong Li; Yan-Nv Huang; Rong Zeng; Nai-He Jing; Taiping Chen; En Li; Hiroyuki Sasaki; Guo-Liang Xu
Journal:  Mol Cell Biol       Date:  2007-10-15       Impact factor: 4.272

Review 3.  microRNA functions.

Authors:  Natascha Bushati; Stephen M Cohen
Journal:  Annu Rev Cell Dev Biol       Date:  2007       Impact factor: 13.827

4.  Bmi1 cooperates with Dnmt1-associated protein 1 in gene silencing.

Authors:  Masamitsu Negishi; Atsunori Saraya; Satoru Miyagi; Kenji Nagao; Yoshimasa Inagaki; Mitsuo Nishikawa; Shoji Tajima; Haruhiko Koseki; Hiroshi Tsuda; Yoshinari Takasaki; Hiromitsu Nakauchi; Atsushi Iwama
Journal:  Biochem Biophys Res Commun       Date:  2006-12-29       Impact factor: 3.575

5.  Identification of DNMT1 (DNA methyltransferase 1) hypomorphs in somatic knockouts suggests an essential role for DNMT1 in cell survival.

Authors:  Gerda Egger; Shinwu Jeong; Sonia G Escobar; Connie C Cortez; Tony W H Li; Yoshimasa Saito; Christine B Yoo; Peter A Jones; Gangning Liang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-08       Impact factor: 11.205

6.  Regional DNA hypermethylation and DNA methyltransferase (DNMT) 1 protein overexpression in both renal tumors and corresponding nontumorous renal tissues.

Authors:  Eri Arai; Yae Kanai; Saori Ushijima; Hiroyuki Fujimoto; Kiyoshi Mukai; Setsuo Hirohashi
Journal:  Int J Cancer       Date:  2006-07-15       Impact factor: 7.396

7.  DNA methylation of multiple tumor-related genes in association with overexpression of DNA methyltransferase 1 (DNMT1) during multistage carcinogenesis of the pancreas.

Authors:  Dun-Fa Peng; Yae Kanai; Morio Sawada; Saori Ushijima; Nobuyoshi Hiraoka; Sohei Kitazawa; Setsuo Hirohashi
Journal:  Carcinogenesis       Date:  2006-03-14       Impact factor: 4.944

8.  Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing.

Authors:  Heinz G Linhart; Haijiang Lin; Yasuhiro Yamada; Eva Moran; Eveline J Steine; Sumita Gokhale; Grace Lo; Erika Cantu; Mathias Ehrich; Timothy He; Alex Meissner; Rudolf Jaenisch
Journal:  Genes Dev       Date:  2007-12-01       Impact factor: 11.361

Review 9.  Immunodeficiency, centromeric region instability, facial anomalies syndrome (ICF).

Authors:  Melanie Ehrlich; Kelly Jackson; Corry Weemaes
Journal:  Orphanet J Rare Dis       Date:  2006-03-01       Impact factor: 4.123

Review 10.  A role for SUMO modification in transcriptional repression and activation.

Authors:  M J Lyst; I Stancheva
Journal:  Biochem Soc Trans       Date:  2007-12       Impact factor: 5.407

View more
  84 in total

Review 1.  DNA methylation and microRNAs in cancer.

Authors:  Xiang-Quan Li; Yuan-Yuan Guo; Wei De
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

Review 2.  Metabolic programming, epigenetics, and gestational diabetes mellitus.

Authors:  Sara E Pinney; Rebecca A Simmons
Journal:  Curr Diab Rep       Date:  2012-02       Impact factor: 4.810

3.  DNA methylation: superior or subordinate in the epigenetic hierarchy?

Authors:  Bilian Jin; Yajun Li; Keith D Robertson
Journal:  Genes Cancer       Date:  2011-06

Review 4.  Epigenetic control of aging.

Authors:  Ursula Muñoz-Najar; John M Sedivy
Journal:  Antioxid Redox Signal       Date:  2010-11-22       Impact factor: 8.401

5.  Protein expression and promoter methylation of the candidate biomarker TCF21 in gastric cancer.

Authors:  Z Yang; D M Li; Q Xie; D Q Dai
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-26       Impact factor: 4.553

6.  Aberrantly silenced promoters retain a persistent memory of the silenced state after long-term reactivation.

Authors:  Jon A Oyer; Phillip A Yates; Sarah Godsey; Mitchell S Turker
Journal:  Mutat Res       Date:  2010-10-28       Impact factor: 2.433

7.  CXXC finger protein 1 contains redundant functional domains that support embryonic stem cell cytosine methylation, histone methylation, and differentiation.

Authors:  Courtney M Tate; Jeong-Heon Lee; David G Skalnik
Journal:  Mol Cell Biol       Date:  2009-05-11       Impact factor: 4.272

8.  Genetic differences and aberrant methylation in the apelin system predict the risk of high-altitude pulmonary edema.

Authors:  Aastha Mishra; Samantha Kohli; Sanchi Dua; Tashi Thinlas; Ghulam Mohammad; M A Qadar Pasha
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-27       Impact factor: 11.205

Review 9.  Cancer-associated fibroblasts in hepatocellular carcinoma.

Authors:  Norio Kubo; Kenichiro Araki; Hiroyuki Kuwano; Ken Shirabe
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

Review 10.  Epigenetic regulation of EBV persistence and oncogenesis.

Authors:  Italo Tempera; Paul M Lieberman
Journal:  Semin Cancer Biol       Date:  2014-01-24       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.